期刊文献+

2型糖尿病及糖尿病肾病患者C反应蛋白水平观察 被引量:17

C-reactive protein levels in type 2 diabetes mellitus and diabetes mellitus with nephropathy
原文传递
导出
摘要 目的观察C反应蛋白水平在2型糖尿病及糖尿病肾病患者时的浓度变化。方法将63例2型糖尿病患者分为糖尿病组(32例)和糖尿病合并肾病组(31例),而以正常体检健康人作为对照组(31例),测定各组的空腹血糖(FPG)、餐后2h血糖(2hPG)、糖化血红蛋白(HbA1c)、血清C反应蛋白(CRP),将组间的C反应蛋白(CRP)进行统计学比较。结果糖尿病组及糖尿病并发肾病组血清C反应蛋白(CRP)均比正常对照组明显升高(P<0.01)。而糖尿病并发肾病组与糖尿病组相比亦明显升高(P<0.01)。结论CRP与糖尿病及其血管慢性并发症有关。 Objective To investigate the C-reactive protein(CRP) concentration in the pathogenesis of type 2 diabetes mellitus(DM) and its nephropathy.Methods Serum CRP levels,blood glucose,HbA1c were measured in 63 diabetes and 31 normal subjects.The difference in prevalence of chronic complication between patients with and without nephropathy was investigated.Results The CRP level was significantly higher in type 2 diabetes mellitus with nephropathy than that in normal control subjects(P<0.01).The CRP level was significantly higher in type 2 diabetes mellitus with than that without nephropathy(P<0.01).Conclusion CRP is related to diabetes mellitus and chronic complication in type 2 diabetes mellitus.
出处 《中国基层医药》 CAS 2005年第6期649-650,共2页 Chinese Journal of Primary Medicine and Pharmacy
关键词 血糖 2型糖尿病 糖尿病肾病 C反应蛋白 C-reactive protein Diabetes mellitus Diabetic nephropathy
  • 相关文献

参考文献10

  • 1李秀钧,邬云红.糖尿病是一种炎症性疾病?[J].中华内分泌代谢杂志,2003,19(4):251-253. 被引量:254
  • 2龙敏.C-反应蛋白和糖尿病[J].国外医学(内分泌学分册),2002,22(2):75-77. 被引量:78
  • 3叶丹,李红.炎症反应相关因子与2型糖尿病[J].国外医学(内分泌学分册),2003,23(5):312-314. 被引量:44
  • 4周全,苗懿德.老年2型糖尿病胰岛素抵抗与冠心病危险因素相关性探讨[J].中国全科医学,2003,6(1):22-24. 被引量:17
  • 5Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med,1999,340:115-116.
  • 6Ridker PM,Hennekens CH,Buring JE,et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. New Engl J Med,2000,23:836-843.
  • 7Haffner SM, Miettien H. Insulin resistance implications for type 2 diabetes mellitus and coronary heart disease. Am J Med, 1997, 103:152-162.
  • 8Nishio Y, Kashiwagi A. Molecular mechanisms of endothelial dysfunction in diabetes mellitus. Nippon Rinsho, 2001,59: 2451-2459.
  • 9Gerstein HC. Glucose: a continuous risk factor for cardiovascular disease. Diabetes Med, 1997,14:25-31.
  • 10Niskanen L,Turpeinen A, Penttila l,et al. Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosis. Diabetes Care, 1998,21:1861-1869.

二级参考文献71

  • 1[1]Howard G,O′Leary D,Zaccaro D,et al.Insulin sensitivity and atherosclerosis.Circulation,1996,93:1809-1817
  • 2[2]Groop L,Ekstrand A,Forsblom C,et al.Insulin resistance,hypertension and microalbuminuria in patients with type II (non-insulin-dependent) diabetes mellitus.Diabetologia,1993,36:642-647
  • 3[3]Steven MHaffner,Ralph D′Agostino Jr,Marian Rewers,et al.Insulin sensitivity in subjects with type 2 diabetes.Diabetes Care,1999,22:562-568
  • 4[4]Matthews DR,Hosker JP,Rudenski AS,et al.Homeostasis model assessment:insulin resistanceand β-cell function from fasting plasma glucose and insulin concentrations in man.Diabetologia,1985,28:412-419
  • 5[5]Bonora E,Kiechl S,Willeit J,et al.Prevalence of insulin resistance in metabolic disorders:the Bruneck Study.Diabetes,1998,47:1643-1649
  • 6[6]Stewart MW,Laker MF,Dyer RG,et al.Lipoprotein compositional abnormalities and insulin resistance in type II diabetic patients with mild hyperlipidemia.Arterioscler Thromb,1993,13:1046-1052
  • 7[8]Fukushima M,Taniguchi A,Sakai M,et al.Effect of bezafibrate on insulin sensitivity in nonobese Japanese type 2 diabetic patients (Letter).Diabetes Care,2000,23:259
  • 8[9]Potter van Loon BJ,Kluft C,Radder JK,et al.The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance.Metabolism,1993,42:945-949
  • 9[10]Morange PE,Aubert J,Peiretti F,et al.Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissue.Diabetes,1999,48:890-895
  • 10[11]Alessi MG,Peirreti F,Morange P,et al.Production of human adipose tissue:Possible link between visceral fat accumulation and vascular disease.Diabetes,1997,46:860-867

共引文献362

同被引文献183

引证文献17

二级引证文献119

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部